Greenbay Biotech International Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 2.74 Cr
as on 16-11-2024
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 124.89%
(FY 2023)
- Profit 1030.12%
(FY 2023)
- Ebitda 253.89%
(FY 2023)
- Net Worth 13.45%
(FY 2023)
- Total Assets 8.41%
(FY 2023)
About Greenbay Biotech International
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.74 Cr, as per Ministry of Corporate Affairs (MCA) records.
Alok Agrawal, Kriti Singh, and Sandeep Agrawal serve as directors at the Company.
- CIN/LLPIN
U74900WB2015PTC205115
- Company No.
205115
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jan 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Greenbay Biotech International Private Limited offer?
Greenbay Biotech International Private Limited offers a wide range of products and services, including Water Treatment & Purification Plant, Watershed Management, Biocides, Microbial Culture.
Who are the key members and board of directors at Greenbay Biotech International?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alok Agrawal  | Director | 28-Jan-2015 | Current |
| Kriti Singh | Director | 15-May-2023 | Current |
| Sandeep Agrawal | Director | 28-Jan-2015 | Current |
Financial Performance and Corporate Structure Insights of Greenbay Biotech International.
Greenbay Biotech International Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 124.89% increase. The company also saw a substantial improvement in profitability, with a 1030.12% increase in profit. The company's net worth Soared by an impressive increase of 13.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Greenbay Biotech International?
In 2023, Greenbay Biotech International had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Terralife Solutions Private LimitedActive 6 years 7 months
Alok Agrawal and Sandeep Agrawal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Greenbay Biotech International?
Unlock and access historical data on people associated with Greenbay Biotech International, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Greenbay Biotech International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Greenbay Biotech International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
